pharmacies must stop selling compounded semaglutide A South African court has ordered pharmacy group iDexis to semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company As pharmacists, we believe patients

This causes the free calcium present in blood to bind strongly with protein

For my pharma savvy folks, this is the Keytruda playbook

If patients begin experiencing adverse outcomes from improperly prescribed GLP-1 medications, both the telehealth providers and uninformed PCPs are likely see a spike in medical negligence claims for inadequate medical oversight, failure to monitor comorbidities and side effects, improper patient selection, drug interaction, or inappropriate discontinuation of treatment

The Kuzminski trial involved 33 patients (18 in the oral arm and 15 in the intramuscular arm), while the Bolaman trial involved 60 (26 in the oral arm and 15 in the intramuscular arm)